Trial intelligence / Profile preview

Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure

NCT07396701Phase 4Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
Feb 2026
Primary completion
Jun 2028
01

Overview

Phase 4, randomised, open-label trial in pneumonia and respiratory failure (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: 28-day mortality rate. Planned start Feb 2026; status: not yet recruiting.

02

Conditions

pneumoniarespiratory failure

Beyond the preview

Go deeper on NCT07396701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07396701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call